Drug selection for the newly diagnosed patients: When is a new generation antiepileptic drug indicated?

Journal of Neurology

Volumn 251, Issue 9, 2004, Pages 1043-1049

  Tomson, Torbjörn ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antiepileptic drugs; Drug therapy; Epilepsy; Review

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; DEXTROPROPOXYPHENE; DILTIAZEM; ETIRACETAM; FELBAMATE; GABAPENTIN; ISONIAZID; LAMOTRIGINE; MACROLIDE; ORAL CONTRACEPTIVE AGENT; OXCARBAZEPINE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VERAPAMIL; VIGABATRIN; ZONISAMIDE;

ABSENCE; APLASTIC ANEMIA; DRUG CHOICE; DRUG CROSS REACTIVITY; DRUG EFFICACY; DRUG TOLERABILITY; EPILEPSY; FOCAL EPILEPSY; GERIATRIC PATIENT; GRAND MAL EPILEPSY; HUMAN; LIVER TOXICITY; MONOTHERAPY; MYOCLONUS SEIZURE; ORAL CONTRACEPTION; OVARY POLYCYSTIC DISEASE; PREGNANCY; PRIORITY JOURNAL; PSYCHOMOTOR DEVELOPMENT; REVIEW; RISK BENEFIT ANALYSIS; SYSTEMATIC REVIEW; TERATOGENICITY; TONIC CLONIC SEIZURE; TUBEROUS SCLEROSIS; VISUAL FIELD DEFECT; WEST SYNDROME;

ANTICONVULSANTS; DRUG INTERACTIONS; EPILEPSY; HUMANS;

EID: 4644265790     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-004-0344-0     Document Type: Review

References (51)

1. Adab N, Jacoby A, Smith D, Chadwick D (2001) Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 70:15-21
2. Arroyo SA, Sander JWAS (1999) Carbamazepine in comparative trials. Pharmacokinetic characteristics too often forgotten. Neurology 53:1170-1174
3. Bauer J, Isojärvi JIT, Herzog AG, et al. (2002) Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management. J Neurol Neurosurg Psychiatry 73: 121-125
4. Bauer J, Jarre A, Klingmuller D, Elger CE (2000) Polycystic ovary syndrome in patients with focal epilepsy: a study in 93 women. Epilepsy Res 41:163-167
5. Bill P, Vigonius U, Pohlmann H, Guerreiro C, Kochen S, Saffer D, Moore A (1997) A double-blind, controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy. Epilepsy Res 27:195-204
6. Brodie MJ, Chadwick DW, Anhut H, et al. (2002) Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy. Epilepsia 43:993-1000
7. Brodie MJ, Overstall PW, Giorgi L, The UK Lamotrigine Elderly Study Group (1999) Multicentre, randomized comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsy Res 37:81-87
8. Brodie MJ, Richens A, Yuen AW (1995) Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 345:476-479
9. Canger R, Battino D, Canevini MP, et al. (1999) Malformations in offspring of women with epilepsy: a prospective study. Epilepsia 40:1231-1236
10. Chadwick DW, Anhut H, Greiner MJ, et al. (1998) A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77. Neurology 51:1282-1288
11. Chadwick D, for the Vigabatrin European Monotherapy Study Group (1999) Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Lancet 354:13-19
12. Chiron C, Dumas C, Jambaqué I, et al. (1997) Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res 26:389-395
13. Christe W, Kramer G, Vigonius U, Pohlmann H, Steinhoff BJ, Brodie MJ, Moore A (1997) A double-blind, controlled clinical trial of oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy. Epilepsy Res 26:451-460
14. Craig J, Russel A, Parsons L, Robertson P, Morrison P, Waddell R, Morrow J (2002) The UK epilepsy and pregnancy registrer: update of results 1996-2002. Abstract Epilepsia 43:56
15. Dam M, Ekberg R, Loyning Y, Waltimo O, Jacobsen K (1989) A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy. Epilepsy Res 3:70-77
16. Eke T, Talbot JF, Lawden MC (1997) Severe persistent visual field constriction associated with vigabatrin. BMJ 314:180-181
17. Elwes RDC, Johnson AL, Shorvon SD, Reynolds EH (1984) The prognosis for seizure control in newly diagnosed epilepsy. New Engl J Med 311:944-947
18. Gaily E (1997) Minor Anomalies and Effects on Psychomotor Development Associated with Maternal Use of Antiepileptic Drugs. In: Tomson T, Gram L, Sillanpää M, Johannessen SI (eds) Epilepsy and Pregnancy. Wrightson Biomedical Publishing Ltd, Petersfield, pp 63-70
19. Guberman A (1999) Hormonal contraception and epilepsy. Neurology 53 (Suppl 1):S38-S40
20. Guerreiro M, Vigonius U, Pohlmann H, Manreza M, Fejerman N, Antoniuk S, Moore A (1997) A double-blind, controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Res 27:205-213
21. Heller AJ, Chesterman P, Elwes RDC, Crawford P, Chadwick D, Johnson AL, Reynolds EH (1995) Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: A randomised comparative monotherapy trial. J Neurol Neurosurg Psychiatry 58:44-50
22. Holmes LB, Harvey EA, Coull BA, et al. (2001)The teratogenicity of anticonvulsant drugs. N Engl J Med 344:1132-1138
23. Isojärvi JJ, Laatikainen TJ, Knip M, Pakarinen AJ, Juntunen KT, Myllyla VV (1996) Obesity and endocrine disorders in women taking valproate for epilepsy. Ann Neurol 39:579-584
24. Isojärvi JI, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllyla VV (1993) Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 329:1383-1388
25. Isojärvi JI, Rättya J, Myllyla VV, et al. (1998) Valproate, lamotrigine, and insulinmediated risks in women with epilepsy. Ann Neurol 43:446-451
26. Kalviainen R, Aikia M, Saukkonen AM, Mervaala E, Riekkinen PJ (1995) Vigabatrin versus carbamazepine monotherapy in patients with newly diagnosed epilepsy: A randomized controlled study. Arch Neurol 52:989-996
27. Kalviainen R, Nousiainen I, Mantyjarvi M, et al. (1999) Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects. Neurology 53:922-926
28. Kaneko S, Battino D, Andermann E, et al. (1999) Congenital malformations due to antiepileptic drugs. Epilepsy Res 33:145-158
29. Kraemer G (2000) Epilepsy in the Elderly: Clinical Aspects and Pharmacotherapy, Georg Thieme Verlag, Stuttgart
30. Krauss GL, Simmonds-O'Brien E, Campbell M (1995) Successful treatment of seizures and porphyria with gabapentin. Neurology 45:594-595
31. Kwan P, Brodie M (2000) Early identification of refractory epilepsy. N Engl J Med 342:314-319
32. Marson AG, Chadwick DW (2001) New drug treatments for epilepsy. J Neurol Neurosurg Psychiatry 70:143-148
33. Marson AG, Kadir ZA, Hutton LJ, Chadwick DW (1997) The new antiepileptic drugs: A systematic review of their efficacy and tolerability. Epilepsia 38:859-880
34. Mattson RH, Cramer JA, Collins JF, Smith DB, Delgado-Escueta AV, Browne TR, Williamson PD, Treiman DM, McNamara JO, McCutchen CB, Homan R, Crill WE, Lubozyuski MF, Rosenthal NP, Mayersdorf A (1985) Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 313:145-151
35. Patsalos PN, Fröscher W, Pisani F, van Rein CM (2002) Importance of drug interactions in epilepsy therapy. Epilepsia 43:365-385
36. Pennell PB, Ogaily MS, Macdonald RL (1995) Aplastic anemia in a patient receiving felbamate for complex partial seizures. Neurology 45:456-460
37. Perucca E, Beghi E, Dulac O, Shorvon S, Tomson T (2000) Assessing risk to benefit ratio in antiepileptic drug therapy. Epilepsy Res 41:107-139
38. Perucca E, Dulac O, Shorvon S, Tomson T (2001) Harnessing the clinical potential of antiepileptic drug therapy: Dosage optimisation. CNS Drugs 15:609-621
39. Perucca E (1996) Principles of drug treatment In: Shorvon SD, Dreifuss F, Fish D, Thomas D (eds) The Treatment of Epilepsy. Blackwell Science, Oxford, pp 152-168
40. Perucca E, Tomson T (1999) Monotherapy trials with the new antiepileptic drugs. Study designs, practical relevance and ethical implications. Epilepsy Res 33:247-262
41. Ramsay RE (1998) Response to treatment and adverse drug effects in the elderly. Epilepsy in The Elderly: Current Concepts in Understanding and Treatment, American Epilepsy Society, CME Monograph, pp 59-64
42. Ramsay RE, Rowan AJ, Slater JD, et al. (1994) Effect of age on epilepsy and its treatment: results from the VA Cooperative Study. Epilepsia 35(Suppl 8):91
43. Sabers A, Ohman I, Christensen J, Tomson T (2003) Oral contraceptives reduce lamotrigine plasma levels. Neurology 26;61(4):570-571
44. Sachdeo RC, Reife RA, Lim P, Pledger G (1997) Topiramate monotherapy for partial onset seizures. Epilepsia 38:294-300
45. Samrén B, van Duijn C, Christiaens GC, Hofman A, Lindhout D (1999) Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 46:739-746
46. Samrén B, van Duijn C, Koch S, Hiilesmaa VK, Klepel H, et al. (1997) Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia 38:981-990
47. Tanganelli P, Regesta G (1996) Vigabatrin vs carbamazepine monotherapy in newly diagnosed focal epilepsy: A randomized response conditional crossover study. Epilepsy Res 25:257-262
48. Tomson T, Kennebäck G (1997) Arrhythmia, heart rate variability, and antiepileptic drugs. Epilepsia 38(Suppl 11):S48-S51
49. Wallace H, Shorvon S, Tallis R (1998) Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2.052.922 and age-specific fertility rates of women with epilepsy. Lancet 352:1970-1973
50. Wide K, Winbladh B, Källén B (2002) Major congenital malformations after intrauterine exposure to antiepileptic drugs especially carbamazepine and valproic acid. Abstract Epilepsia 43:159
51. Willmore LJ (1995) The effect of age on pharmacokinetics of antiepileptic drugs. Epilepsia 36(Suppl 5):S14-S21